Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
plant inspections
Pharma
Dr. Reddy's hit with ban from China's drug procurement program
Dr. Reddy’s has been blacklisted from China’s drug procurement program after a plant inspection turned up multiple production snafus.
Fraiser Kansteiner
Sep 3, 2024 3:56pm
FDA hits Aurobindo's Eugia with 'Official Action Indicated' tag
Aug 6, 2024 8:50am
Daewoong Bio banned from China drug procurement program
Jul 19, 2024 10:21am
Inside the FDA concerns that sank Hengrui's PD-1 drug filing
Jul 16, 2024 4:50pm
UPDATED: Elevar, Hengrui eye accelerated refile for PD-1 combo
Jul 12, 2024 12:08am
FDA hits Biocon's insulin copycat with a CRL
Oct 9, 2023 11:53am
